Medication Guide · Updated November 2026
Mounjaro Dosage Guide: What to Expect From 2.5mg to 15mg
Tirzepatide starts at 2.5mg once weekly for 4 weeks, then goes up in 2.5mg steps no sooner than every 4 weeks, to a maximum of 15mg. In the SURMOUNT-1 trial, average weight loss at 72 weeks was 15.0% at 5mg, 19.5% at 10mg, and 20.9% at 15mg. The Zepbound label lists 5mg, 10mg, and 15mg as maintenance doses for weight, so not everyone needs the top dose. Here is what to expect at each level.
A note on names: Mounjaro is FDA-approved for type 2 diabetes. Zepbound is the same drug (tirzepatide) approved for weight reduction and sleep apnea. The weight-loss dosing below follows the Zepbound prescribing information. The Mounjaro prescribing information uses the same 2.5mg start, 2.5mg steps, and 15mg maximum for adults with diabetes.
The Standard Titration Schedule
| Dose | Earliest weeks | Purpose |
|---|---|---|
| 2.5 mg | Weeks 1-4 | Starting dose. The label says it is for treatment initiation and is not approved as a maintenance dose. |
| 5 mg | Weeks 5-8 | First dose the Zepbound label lists as a maintenance option. |
| 7.5 mg | Weeks 9-12 | Step between maintenance doses. |
| 10 mg | Weeks 13-16 | Maintenance option for weight and for sleep apnea. |
| 12.5 mg | Weeks 17-20 | Step between maintenance doses. |
| 15 mg | Week 21 onward | Maximum labeled dose. |
The 4-week rule: The label says to increase in 2.5mg steps “after at least 4 weeks on the current dose.” These are the fastest possible weeks, not targets. Your prescriber can keep you at a dose longer. Rushing increases the chance of stomach side effects. For a detailed look at what side effects to expect during titration, see our month-by-month guide.
You do not have to reach 15mg. The label tells prescribers to weigh treatment response and tolerability when picking a maintenance dose, and to consider a lower maintenance dose if a higher one is not tolerated.
Dose-by-Dose Breakdown
2.5 mg (Weeks 1-4): The Warm-Up
The 2.5mg starting dose exists to let your body adjust to tirzepatide before the doses that SURMOUNT-1 tested for weight loss. The label describes it as a starting dose only.
What to expect:
- Some appetite reduction, often mild
- Little change on the scale for many people
- Mild nausea for a day or two after the injection in some people
- Possibly no side effects at all
My experience: I barely noticed 2.5mg. Slight appetite reduction. No nausea. I wondered if the medication was actually working. It was. My body was quietly adjusting.
What the data says: In the pooled weight-loss trials in the Zepbound label, nausea was reported by 25% of people on 5mg, 29% on 10mg, and 28% on 15mg, versus 8% on placebo. Vomiting rose with dose: 8%, 11%, and 13%, versus 2% on placebo.
5 mg (Weeks 5-8): Things Start Happening
This is the first dose where many people feel the medication is “really working.” Appetite suppression becomes more noticeable.
What to expect:
- Clearer appetite suppression. Portions shrink naturally.
- Nausea may increase, especially the first week at this dose
- “Food noise” reduction (less constant thinking about food)
- Constipation may appear (slower stomach emptying)
My experience: The jump to 5mg was when I thought “okay, this is real.” My appetite dropped significantly. I could eat half a meal and feel full. Nausea was present for the first 3-4 days after the dose increase, then faded.
Clinical data: In SURMOUNT-1, the 5mg group lost 15.0% of body weight on average at 72 weeks. Participants started at an average of 104.8 kg (about 231 lbs), so that works out to roughly 35 lbs. 85% of the 5mg group lost at least 5% of their weight. The Zepbound label lists 5mg as one of three maintenance doses.
7.5 mg (Weeks 9-12): A Common Stopping Point
SURMOUNT-1 did not test 7.5mg as its own group. It was a step on the way to 10mg and 15mg. Some people and prescribers decide to stay here for a while when things are going well.
What to expect:
- Stronger appetite suppression than 5mg
- Food aversions may develop (often to fried or very sugary food)
- Nausea may come back briefly after the increase, then settle
- Energy levels may fluctuate during the first week
My experience: 7.5mg was where I felt most comfortable. The appetite suppression was strong but not overwhelming. I could eat reasonable meals without feeling sick. I stayed at this dose for an extra month before going up because things were working well.
Key point: If you are losing weight steadily and feeling good at 7.5mg, there is no rush to increase. Your prescriber may agree to keep you here.
10 mg (Weeks 13-16): Strong Therapeutic Dose
10mg was its own study group in SURMOUNT-1 and is a labeled maintenance dose.
What to expect:
- Very strong appetite suppression (some people struggle to eat enough)
- Risk of eating too little, especially protein
- Nausea may return during the transition, then resolve
- Sulfur burps may increase (eructation was reported by 5% of people on 10mg in the label’s pooled data)
Clinical data: In SURMOUNT-1, the 10mg group lost 19.5% of body weight on average at 72 weeks (roughly 45 lbs from the average starting weight). 50% of the 10mg group lost 20% or more of their body weight.
Nutrition note: At 10mg and above, appetite suppression can be strong enough that people undereat, especially protein. A 2025 joint nutrition advisory from four obesity and nutrition societies notes that targets of 1.2 to 1.6 grams per kilogram of body weight per day (about 0.55 to 0.73 grams per pound) have been proposed during active weight loss, and that using total body weight can overestimate needs in people with obesity. If you have kidney disease, ask your doctor before raising protein. See our exercise and muscle guide for more.
Track your body composition (not just weight) to catch muscle loss early. See our body composition tool.
12.5 mg and 15 mg (Weeks 17+): Maximum Doses
12.5mg is a titration step. 15mg is the maximum labeled dose. These are usually considered when weight loss at 10mg is not enough and side effects allow.
What to expect at 12.5-15mg:
- Strongest appetite suppression
- Some patients report little interest in eating at all
- GI side effects may increase again at these levels
- Weight loss often continues at a slower rate than the early months
- Careful nutritional monitoring becomes more important
Clinical data (15mg): In SURMOUNT-1, the 15mg group lost 20.9% of body weight on average at 72 weeks (roughly 48 lbs from the average starting weight). 91% lost at least 5% and 57% lost 20% or more. The gap between 10mg and 15mg (19.5% vs 20.9%) was much smaller than the gap between placebo (3.1%) and 5mg (15.0%).
My perspective: Not everyone needs to reach 15mg. The average difference in weight loss between 10mg and 15mg in SURMOUNT-1 was about 1.4 percentage points, while vomiting and diarrhea were somewhat more common at 15mg in the label’s pooled data. Talk to your prescriber about whether the higher dose is worth it for your situation. If you and your prescriber disagree about moving up, this guide on a doctor who won’t increase your dose walks through your options.
Safety Points From the Label
These apply at every dose. Read the full Zepbound prescribing information and follow your prescriber.
- Thyroid tumor warning. The label carries a boxed warning: tirzepatide caused thyroid C-cell tumors in rats, and it is unknown whether it does in people. Do not use it if you or a family member has had medullary thyroid carcinoma, or if you have MEN 2.
- Pancreatitis. Severe stomach pain that may spread to the back, with or without vomiting, needs prompt medical attention. The label says to stop the drug if pancreatitis is suspected.
- Gallbladder and kidneys. Gallbladder problems were more common with tirzepatide. Vomiting and diarrhea can cause dehydration, which can affect the kidneys, so call your prescriber if you cannot keep fluids down.
- Birth control pills. The label advises people on oral contraceptives to switch to a non-oral method, or add a barrier method, for 4 weeks after starting and for 4 weeks after each dose increase.
- Pregnancy. The label says weight loss offers no benefit during pregnancy and to stop Zepbound when a pregnancy is recognized.
- Missed dose. Take it within 4 days (96 hours). If more than 4 days have passed, skip it and take the next dose on your regular day.
When to Stay vs. When to Increase
Talk to your prescriber about staying at your current dose if:
- You are losing weight steadily
- Side effects are manageable
- You feel good and appetite suppression is working
- Your lab work is stable
Talk to your prescriber about increasing if:
- Weight loss has stalled for several weeks
- Appetite suppression is noticeably weakening
- Your prescriber recommends it based on your clinical picture
Do NOT push for an increase if:
- You are having significant side effects at the current dose
- You are not eating enough (under-eating is not a sign you need more medication)
- You are trying to “speed up” weight loss artificially
Tirzepatide vs. Semaglutide Titration Comparison
| Feature | Tirzepatide (Zepbound) | Semaglutide (Wegovy injection) |
|---|---|---|
| Starting dose | 2.5 mg weekly | 0.25 mg weekly |
| Weight-loss maintenance doses | 5, 10, or 15 mg | 1.7 or 2.4 mg, with 7.2 mg as an option after at least 4 weeks on 2.4 mg |
| Max dose | 15 mg | 7.2 mg |
| Earliest week at usual top maintenance dose | Week 21 (15 mg) | Week 17 (2.4 mg) |
| Dose steps | 2.5, 5, 7.5, 10, 12.5, 15 | 0.25, 0.5, 1, 1.7, 2.4, 7.2 |
| Main trial weight loss | 20.9% at 15 mg (SURMOUNT-1, 72 wks) | 14.9% at 2.4 mg (STEP 1, 68 wks) |
| Head-to-head result | 20.2% (SURMOUNT-5, 72 wks) | 13.7% (SURMOUNT-5, 72 wks) |
Wegovy dosing is from the Wegovy prescribing information. The two main trials enrolled different people, so compare them with care. SURMOUNT-5 is the direct comparison. For the full clinical comparison, see our Mounjaro vs Ozempic comparison. Already on Ozempic? Switching from Ozempic to Mounjaro explains what changes.
Find a GLP-1 provider
Compare Providers →The Bottom Line
Tirzepatide’s titration schedule is designed to limit side effects while you find your effective dose. Not everyone needs to reach 15mg. In SURMOUNT-1, the biggest jump came from placebo to 5mg, and the step from 10mg to 15mg added much less on average. Prioritize protein at every dose level, track your body composition (not just weight), and work with your prescriber to find the dose that gives you good results with tolerable side effects. If cost is a factor, check our cheapest GLP-1 guide.
If you are starting a GLP-1 program, compare providers in our directory. For side effect management at each dose, see our GLP-1 side effects guide.
FAQ
How fast should I titrate Mounjaro?
The label allows an increase of one 2.5mg step after at least 4 weeks on the current dose: 2.5mg for 4 weeks, then 5mg for at least 4 weeks, and so on. Some prescribers keep patients at a dose longer to limit side effects. Do not increase faster than every 4 weeks.
What if I feel fine at a lower dose?
Talk to your prescriber about staying there. The Zepbound label lists 5mg, 10mg, and 15mg as maintenance doses and tells prescribers to weigh response and tolerability. The right dose is the one that produces steady weight loss with tolerable side effects.
Can I go back down if a dose is too much?
The label tells prescribers to consider a lower maintenance dose if a patient does not tolerate a higher one. If a dose increase causes side effects you cannot manage, talk to your prescriber before changing anything yourself.
How much weight should I lose at each dose?
There is no fixed target. In SURMOUNT-1, average weight loss at 72 weeks was 15.0% at 5mg, 19.5% at 10mg, and 20.9% at 15mg, which is roughly 35, 45, and 48 lbs from the average starting weight of about 231 lbs. Individual results vary widely.
Does Mounjaro stop working at higher doses?
No, but weight loss usually slows over time at any dose as your body adapts to a lower weight. A slowdown does not by itself mean the medication has stopped working. Talk to your prescriber before stopping. In the SURMOUNT-4 trial, people switched to placebo saw their weight rise 14.0% over the next 52 weeks.
Related
Guides:
- Cheapest GLP-1 Online · Insurance Coverage · Side Effects
- Mounjaro Dosage Guide · Oral vs Injectable · Exercise and Muscle
- Compounded vs Brand-Name · Without Insurance · Tirzepatide mg to Units Chart
- Fat Loss vs Weight Loss · DEXA Scan Results · Mounjaro Plateau · Medicare Coverage · Wegovy Pill vs Injection
Provider Reviews: Ro · Hims · MEDVi · Found · Calibrate
Compare: All Providers · Best GLP-1 Programs · All Guides
What we checked
This AI-assisted public-source desk check reviewed the Zepbound, Mounjaro, and Wegovy prescribing information, the SURMOUNT-1, STEP 1, and SURMOUNT-5 trial publications, and a 2025 joint nutrition advisory on November 4, 2026. This is not a clinical review and it is not medical advice. Prices and policies change, so confirm them with the provider or your prescriber before you act.